A victory for Natural Alternatives International in its beta alanine patent case is being heralded as a huge IP protection precedent in the natural products industry.
The splits in the organic movement have given birth to a new initiative to regain the soul of the concept, according to an executive with a major retailer.
The proposed 2020 budget for FDA includes a request for mandatory registration of dietary supplements as well as decreased funding for research into these products, according to an analysis supplied to NutraIngredients-USA.
With growth “like a rocket ship”, a new range of hemp-CBD products, and a continued commitment to keto and protein, “2019 is going to be a great year”, says Ancient Nutrition product innovator and founder, Jordan Rubin.
Six people and two companies have been charged by federal prosecutors for allegedly selling illegal drugs masquerading as supplements in a case filed Wednesday in Florida.
Medical marijuana may soon make some progress in India, but any hope of more relaxed regulations on CBD or hemp for nutraceuticals has gone up in smoke, according to one industry expert.
Dr Ned Sharpless, MD, who is the current head of the National Cancer Institute, will be the interim head of the Food and Drug Administration when Dr Scott Gottlieb, MD, leaves next month.
Spanish firm Interquim SA, part of the pharmaceutical company Ferrer, announced that the FDA has no objections to the company’s Generally Recognized as Safe (GRAS) claim for its standardized orange extract.
Network marketing company Nature’s Sunshine recorded sales increases driven largely by rising sales in China, which is a relatively new market for the company.
By FROM THE EDITOR'S DESK: Confusion in the certification game
Do certifications within the supplement industry provide meaningful information to consumers? Or are they just a way to make a confusing market even more impenetrable?
The advocates for the reformation of the regulation of hemp derivatives in nutritional products were clinging to the hope that the abrupt resignation of FDA Commissioner Dr Scott Gottlieb will not mean the initiative will be stillborn.
Stakeholders from the dietary supplements and food industries have been reacting to the resignation of Scott Gottlieb, MD, with many pushing for the Agency to follow through on the key initiatives started during his leadership.
By Will Chu, Niamh Michail, Hank Schultz, and Cheryl Tay
The interest in cannabidiol (CBD) use in food supplements, foods, and even as an ingredient in cosmetics has gained much momentum in the past five years, but what is the regulatory situation around the world?
